Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement
Research over the past decade has resulted in the development of two commercial interferongamma release assays (IGRAs), based on the principle that the T-cells of individuals who have acquired TB infection respond to re-stimulation with Mycobacterium tuberculosis-specific antigens by secreting interferon...